Monkeypox
Symptoms, Doctors, Treatments, Advances & More

Monkeypox Overview

Save information for later
Sign Up

Learn About Monkeypox

What is the definition of Monkeypox?
Monkeypox is a rare viral infection caused by the monkeypox virus. The monkeypox virus is in the same family of viruses that cause smallpox. However, an infection with monkeypox is usually milder than smallpox.
What are the causes of Monkeypox?
Monkeypox can be contracted through skin-to-skin contact with an infected person or their body fluids, breathing in the virus through face-to-face contact, through sexual contact, touching items that were used by an infected person, from maternal-to-infant transmission during pregnancy, and bites from infected animals.
What are the symptoms of Monkeypox?
Symptoms of monkeypox usually appear three weeks after exposure to the virus. Symptoms of monkeypox vary by individual and can be mild to severe. Symptoms of monkeypox may include a rash that looks like pimples or blisters, headache, fatigue, fever, sore throat, nasal congestion, cough, chills, muscle aches, backache, and swollen lymph nodes. The rash may appear on the genitals, anus, mouth, face, chest, and hands. The pimples or blisters may be painful and itchy. The rash progresses to scabs before healing. Individuals with monkeypox remain contagious to others until all the scabs have completely healed, usually within two-to-four weeks.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Monkeypox?
Mild monkeypox infections will usually heal without treatment within two-to-four weeks. Treatment for monkeypox includes antiviral drugs such as tecovirimat, prescription mouthwashes, stool softeners, and topical gels and creams.
Who are the top Monkeypox Local Doctors?
Elite in Monkeypox
Dr. Inger K. Damon
Internal Medicine
Elite in Monkeypox
Dr. Inger K. Damon
Internal Medicine

Office

1627 Clairmont Ln NE, 
Atlanta, GA 
404-717-5167
Languages Spoken:
English

Inger Damon is a primary care provider, practicing in Internal Medicine in Atlanta, Georgia. Dr. Damon is rated as an Elite provider by MediFind in the treatment of Monkeypox. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Monkeypox, Smallpox, Rabies, and Ebola Virus Disease.

Elite in Monkeypox
Elite in Monkeypox
Referral may be required
Kinshasa, KN, CD 

Elisabeth Pukuta practices practicing medicine in Kinshasa, Democratic Republic of the Congo. Ms. Pukuta is rated as an Elite expert by MediFind in the treatment of Monkeypox. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Monkeypox, Rabies, Ebola Virus Disease, and Togaviridae Disease.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Monkeypox
Elite in Monkeypox
Referral may be required
Kinshasa, KN, CD 

Stomy Karhemere practices practicing medicine in Kinshasa, Democratic Republic of the Congo. Karhemere is rated as an Elite expert by MediFind in the treatment of Monkeypox. They are also highly rated in 2 other conditions, according to our data. Their clinical expertise encompasses Monkeypox, Rabies, Smallpox, and Chickenpox.

View All Doctors
What are the latest Monkeypox Clinical Trials?
Evaluation of the Effectiveness and Safety of the LC16m8 Mpox Vaccine in Individuals Aged One Year and Older in the Democratic Republic of Congo (DRC)
Evaluation of the Effectiveness and Safety of the LC16m8 Mpox Vaccine in Individuals Aged One Year and Older in the Democratic Republic of Congo (DRC)
Enrollment Status: Recruiting
Publish Date: August 31, 2026
Intervention Type: Biological

Summary: This is a health facility-based prospective test-negative (TND) case-control study to evaluate vaccine effectiveness and active safety monitoring (cohort event monitoring), and passive surveillance for evaluation of the safety of the LC16m8 mpox vaccine in individuals aged one year and older in the DRC. This study aims to assess the LC16m8 vaccine effectiveness and safety. The following activities...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Safety, Reactogenicity, and Immunogenicity of an Mpox mRNA Vaccine Candidate, BNT166a, in Healthy Participants Aged 18 Years and Older in African Countries: A Randomized, Double-blind, Placebo-controlled Phase II Trial
Safety, Reactogenicity, and Immunogenicity of an Mpox mRNA Vaccine Candidate, BNT166a, in Healthy Participants Aged 18 Years and Older in African Countries: A Randomized, Double-blind, Placebo-controlled Phase II Trial
Enrollment Status: Recruiting
Publish Date: August 11, 2026
Intervention Type: Other, Biological
Study Phase: Phase 2

Summary: This is a randomized, double-blind, placebo-controlled study which aims to assess the safety, reactogenicity, and immunogenicity after one and two doses of BNT166a or placebo in healthy participants.

View All Clinical Trials